期刊文献+

脂质体微泡对超声介导基因转染的增效作用研究 被引量:2

The enhanced effects of liposome microbubble under ultrasound mediated gene transfection conditions
原文传递
导出
摘要 目的探讨超声介导基因转染时,脂质体微泡(LM)对体内、外红色荧光蛋白基因(RFP)转染的增效作用及其安全性。方法将RFP和LM加入培养的Hela细胞后行超声辐照(US).对微泡浓度、超声强度、辐照时间进行优化研究,运用荧光显微镜、流式细胞术评估基因转染率,并对细胞损伤进行分析。在裸鼠移植瘤的体内实验中,将LM和RFP质粒(P)经尾静脉注入后予以超声辐照(P+LM+US),以单纯质粒注射(P)、P+US、P+LM作为对照,行冰冻切片,组织学检查,RFP表达检测。结果培养的Hela细胞经LM和超声辐照联合处理后,RFP基因转染率显著增加,差异有统计学意义(P〈0.01),在超声强度为1.0W/cm2、微泡浓度为6%、辐照3min的条件下最显著,且未发现显著的细胞损伤。P+LM+US组的裸鼠移植瘤内RFP表达显著高于P组、P+US组或P+LM组,差异均有统计学意义(P〈0.01),且未观察到明显的组织损伤。结论LM对超声介导基因转染的体内、外转染效率有显著的增效作用,而无明显的细胞或组织损伤。为临床基因治疗提供一种新颖、高效、安全的非病毒基因转染方法。 Objective To study the transfection efficiency and safety of liposome microbubble(LM) on red fluorescent protein(RFP) in vitro and in vivo under ultrasound mediated gene transfection(USMGT) conditions. Methods Plasmids containing RFP were added to cultured Hela cells followed by ultrasound (US) exposure with LM. Different concentration of LM, US intensity and exposure time were optimized. Transfection efficiency was evaluated by fluorescent microscopy and FACS. Cell viability was verified by propidium iodide assay. In transplanted tumors in vivo study, LM and plasmid(P) were injected into the nude mice followed by US exposure (P + LM + US group). Nude mice undergoing plasmid injection alone (P group) ,plasmid injection and US exposure (P+ US group) and plasmid and LM injection (P + LM group) were used as controls. Frozen section and histological examination were conducted and RFP expression was evaluated. Results LM and US exposure significantly increased transfection efficiency in cultured Hela cells ( P〈0.01 ). Transfection efficiency was the most prominent under the condition of US intensity of 1.0 W/cm2 with 6% LM,duration 3 min. No apparent cell damage was found in the all groups. In transplanted tumors, strong RFP was seen in P + LM + US group. It was significantly higher than in any other groups ( P 〈0.01). No tissue damage was seen histologically. Conclusions LM could enhance USMGT effectively without causing any apparently adverse effect in vitro and in vivo. This melhod would be a novel,effective, safe non-viral gene transfection method and provide an ahernative to current clinical gene therapy.
出处 《中华超声影像学杂志》 CSCD 北大核心 2009年第1期62-66,共5页 Chinese Journal of Ultrasonography
基金 基金项目:国家自然科学基金面上项目资助(30670548,30872422)
关键词 超声检查 微气泡 脂质体 转染 基因疗法 Uhrasonography Microbubbles Liposomes Transfection Gene therapy
  • 相关文献

参考文献12

  • 1Mehier-Humbert S,Guy RH. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev, 2005,57 :733-753.
  • 2FeriI LB Jr, Ogawa R, Tachibana K, et al. Optimized ultrasoundmediated gene transfection in cancer cells. Cancer Sci, 2006, 97: 1111-1114.
  • 3Leong-Poi H, Kuliszewski MA, Lekas M, et al. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res, 2007, 101 : 295-303.
  • 4Li T, Tachibana K, Kuroki M, et al. Gene transfer with echoenhanced contrast agents:comparison between Albunex, Optison, and Levovist in mice-initial results. Radiology, 2003,229: 423- 428.
  • 5Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gent Ther, 2002,9 : 372-380.
  • 6Suzuki R, Takizawa T, Negishi Y, et al. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology. Int J Pharm, 2008,354 : 49-55.
  • 7Vandenbroucke RE, Lentacker I, Demeester J, et al. Ultrasound assisted siRNA delivery using PEG-siPlex loaded mierobubbles. J Control Release, 2008,126 : 265-273.
  • 8周忠江,叶海燕,张新宇,查道刚,吴平生,刘伊丽.超声介导载基因微泡靶向传输血管内皮生长因子促心肌血管新生[J].中华心血管病杂志,2004,32(5):438-441. 被引量:7
  • 9谭开彬,高云华,刘平,刘政,杨莉,左松.机械振荡法制备脂膜超声造影剂的初步实验研究[J].中国超声医学杂志,2006,22(8):561-563. 被引量:14
  • 10刘苏,王志刚.超声微泡介导绿色荧光蛋白基因在视网膜神经节细胞表达的实验研究[J].中华超声影像学杂志,2007,16(4):353-356. 被引量:9

二级参考文献28

  • 1谭开彬,高云华,刘平,左松,刘政,朱贤胜.自制脂膜氟烷声学造影剂增强肾脏灰阶显像的实验研究[J].中华超声影像学杂志,2003,12(5):45-47. 被引量:4
  • 2PingLiu Yun-HuaGao Kai-BinTan ZhengLiu SongZuo.Grey scale enhancement of rabbit liver and kidney by intravenous injection of a new lipid-coated ultrasound contrast agent[J].World Journal of Gastroenterology,2004,10(16):2369-2372. 被引量:3
  • 3Laham R, Simons M. Therapeutic angiogenesis in myocardial ischemia.In: Ware JA, Simons M,eds. Angiogenesis and Cardiovascular Disease. Oxford: Oxford University Press, 1999.289-320.
  • 4Morishita R, Aoki M, Kaneda Y, et al. Gene therapy in vascular medicine: recent advances and future perspectives. Pharmacol Ther,2001,91:105-114.
  • 5Li JJ, Ueno H, Yamamoto H, et al. Quantitative analysis of repeat adenovirus mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol,1995,15:2246-2253.
  • 6Lawrie A, Brisken AF, Francis SE, et al. Microbubble-enhanced ultrasound for vascular gene delivery. Gene therapy, 2000, 7:2023-2027.
  • 7Folkman J. Angiogenic therapy of human heart. Circulation, 1998,97:628-629.
  • 8Isner JM, Piecezk A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patients with ischemic limb. Lancet, 1996, 348:370-374.
  • 9Rosengart TK, Lee LY, Patel SR, et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Sur
  • 10Yancopoulos GD, Davis S, Gale NW. et al. Vascular-specific growth factors and blood vessel formation. Nature, 2000, 407:242-248.

共引文献27

同被引文献30

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部